Real world evidence on the effectiveness and safety of tofacitinib in ulcerative colitis in Lebanon
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Real world evidence on the effectiveness and safety of tofacitinib in ulcerative colitis in Lebanon ; volume:24 ; number:1 ; day:4 ; month:10 ; year:2024 ; pages:1-7 ; date:12.2024
BMC gastroenterology ; 24, Heft 1 (4.10.2024), 1-7, 12.2024
- Creator
-
Sharara, Ala I.
Alrazim, Ayman
Saniour, Philippe
Daniel, Fady
Rached, Antoine Abou
Bahr, Abbas
Azar, Cecilio
Geagea, Antoine
Ghoubar, Marcelle
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12876-024-03341-5
- URN
-
urn:nbn:de:101:1-2412202128137.749612673773
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sharara, Ala I.
- Alrazim, Ayman
- Saniour, Philippe
- Daniel, Fady
- Rached, Antoine Abou
- Bahr, Abbas
- Azar, Cecilio
- Geagea, Antoine
- Ghoubar, Marcelle
- SpringerLink (Online service)
Other Objects (12)
Tofacitinib: An Option for Acute Severe Ulcerative Colitis?
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis
Cost Effectiveness of Tofacitinib for the Treatment of Moderate to Severe Active Ulcerative Colitis in Colombia
Safety and effectiveness of tofacitinib in Korean adult patients with ulcerative colitis: post-marketing surveillance study
Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis
Impact of Concomitant Corticosteroids on Tofacitinib Induction Efficacy and Infection Rates in Ulcerative Colitis
Cost-Effectiveness Analysis of Tofacitinib Compared with Biologics in Biologic-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan
Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database
5 Jahre Tofacitinib bei Colitis ulcerosa
Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes
Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitis
Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials
Tofacitinib: An Option for Acute Severe Ulcerative Colitis?
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis
Cost Effectiveness of Tofacitinib for the Treatment of Moderate to Severe Active Ulcerative Colitis in Colombia
Safety and effectiveness of tofacitinib in Korean adult patients with ulcerative colitis: post-marketing surveillance study
Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis
Impact of Concomitant Corticosteroids on Tofacitinib Induction Efficacy and Infection Rates in Ulcerative Colitis
Cost-Effectiveness Analysis of Tofacitinib Compared with Biologics in Biologic-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan
Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database
5 Jahre Tofacitinib bei Colitis ulcerosa
Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes
Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitis
Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials
Tofacitinib: An Option for Acute Severe Ulcerative Colitis?
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis
Cost Effectiveness of Tofacitinib for the Treatment of Moderate to Severe Active Ulcerative Colitis in Colombia
Safety and effectiveness of tofacitinib in Korean adult patients with ulcerative colitis: post-marketing surveillance study
Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis
Impact of Concomitant Corticosteroids on Tofacitinib Induction Efficacy and Infection Rates in Ulcerative Colitis
Cost-Effectiveness Analysis of Tofacitinib Compared with Biologics in Biologic-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan
Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database
5 Jahre Tofacitinib bei Colitis ulcerosa
Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes
Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitis